With an age-old study, researchers from CU Boulder developed a novel ultra-time efficient exercise to control blood pressure. It is known as inspiratory muscle strength training. Initially, it developed in the 1980s to keep critical people off ventilators. This exercise included brisk breathing with the help of a hand-held device. With the new training, researchers focused on strength training for muscles along with breathing.
Managed Muscle Energy can Save People from Different Damages
The key findings of the study will help individuals exercise at ease without changing clothes or going into a proper setup. It is also highly beneficial in lowering blood pressure, and boosting physical and cognitive performance.
When the researchers from the University of Arizona examined 30 inhalations, the performance improved every day. This is due to the greater resistance that helped them obstruct sleep apnea. Moreover, having a stronger diaphragm and restful sleep with efficient inspiratory muscles showed astonishing results. The systolic blood pressure plunged 12 millimeters of mercury, twice the results of aerobic exercise and way more than medication can deliver. Systolic blood pressure symbolizes pressure in vessels. Heartbeat increases as arteries stiffen with age. This can also increase the chances of a heart attack due to damaged blood-starved tissue, kidney damage or cognitive decline.
IMST lead to a significant drop in blood pressure and improved functions in large arteries. It also performed better on various memory and cognitive tests as well. Furthermore, people following IMST could spend a long time on the treadmill and consume lower oxygen during exercise. However, researchers are pressuring on further research and spreading awareness about consulting doctors before adopting IMST.
In a study, conducted by a team working with Prof. Karl-Heinz Ladwig researchers from the Technical University of Munich have come up with entirely new conclusion. They stated that treating patients with blood pressure earlier could negatively affect patient mental health and doesn’t reduce the risk of heart diseases. This analysis came after the American College of Cardiology provided a new guideline for high blood pressure for stage 1 hypertension. In this stage, patients whose blood pressure lies between 130-139 mmHg and 80-89 mmHg require treatment by doctors. Whereas, according to the European Society of Cardiology, patients under this category do not require any specific treatment.
Early Diagnoses Mostly Have Minimal Effects of Patients
Prof. Karl-Heinz explains that the intention behind the U.S. guidelines is to curb blood pressure at the earliest. This will encourage patients to adopt a healthier lifestyle. However, he also stated that this motivational factor is controversial, as most of the people are not ready to change their lifestyle despite the diagnosis. Stage 2 hypertension is the stage where both the U.S. and the European guidelines recommend medication, but not in stage 1 hypertension. This is because CVD mortality risk was found to be not high in people with normal blood pressure.
Depression Plays a Contrary Role for People with High Blood Pressure
Contrary to the common notion, the incidence of depression is lower among the population set with very high blood pressure. Depression was high among the people who were taking medicines to treat hypertension. Moreover, Ladwig said that when people are informed about the sickness, it somewhere affects their mental wellbeing. Ladwig has also proved this in his previous study that showed mortality risk from cardiovascular disease and found that depression risk is linked to obesity or high cholesterol.
Therefore, it will be a serious mistake to adopt the U.S. guidelines in Europe, according to Ladwig.